EXHIBIT 10(c)

                                                               EXECUTION VERSION

            REGISTRATION  RIGHTS AGREEMENT,  dated as of December 6,
            2006   (this   "AGREEMENT"),    by   and   among   Elite
            Pharmaceuticals,   Inc.,  a  Delaware  corporation  (the
            "COMPANY"),  VGS Pharma,  a Delaware  limited  liability
            company  ("VGS")  and  Veerappan  Subramanian  ("VS" and
            together with VGS, the "INITIAL INVESTORS").
            --------------------------------------------------------

                            INTRODUCTION

      In connection with that certain Strategic Alliance Agreement,  dated as of
December 6, 2006,  by and among the parties  hereto of even date  herewith  (the
"ALLIANCE AGREEMENT"), the Company has agreed, upon the terms and subject to the
conditions  contained  therein,  to (x)  issue  and  sell  to VGS  957,396  (the
"PURCHASED  SHARES")  shares of Common  Stock,  par value  $0.01 per share  (the
"COMMON STOCK") of the Company and (y) grant to VGS a warrant (the "WARRANT") to
acquire an aggregate of 478,698  shares (the "Warrant  Shares") of Common Stock,
upon the terms and conditions and subject to the  limitations and conditions set
forth in the Warrant;

      In connection  with that certain  Advisory  Agreement,  by and between the
Company and VS of even date herewith (the "Advisory Agreement"), the Company has
agreed, upon the terms and subject to the conditions contained therein, to grant
to VS options  (the  "OPTIONS")  exercisable  for up to  1,750,000  shares  (the
"OPTION SHARES") of Common Stock, as the same may be adjusted,  pursuant to that
certain Stock Option Agreement,  dated as of the date hereof, by and between the
Company and VS (the "STOCK OPTION AGREEMENT"); and

      To induce the  Initial  Investors  to execute  and  deliver  the  Alliance
Agreement and the Advisory Agreement,  the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended,  and the rules
and regulations thereunder, or any similar successor statute (collectively,  the
"1933 ACT"), and applicable state securities laws.

                                    AGREEMENT

      NOW, THEREFORE,  in consideration of the premises and the mutual covenants
contained  herein and other good and  valuable  consideration,  the  receipt and
sufficiency  of which  are  hereby  acknowledged,  the  Company  and each of the
Initial Investors hereby agree as follows:

            1. DEFINITIONS.

                  a. As used in this  Agreement,  the following terms shall have
the following meanings:

                        (i)  "INVESTORS"  means the  Initial  Investors  and any
transferee  or assignee  who agrees to become  bound by the  provisions  of this
Agreement in accordance with Section 7 hereof.

                        (ii) "register,"  "registered," and "registration" refer
to a registration  effected by preparing and filing a Registration  Statement or
Statements  in  compliance  with the 1933 Act and pursuant to Rule 415 under the
1933 Act or any successor rule providing for offering securities on a continuous
basis ("RULE 415"), and the declaration or



ordering of  effectiveness of such  Registration  Statement by the United States
Securities and Exchange Commission (the "SEC").

                        (iii)   "Registrable   Securities"  means  the  (w)  the
Purchased  Shares,  (x) the  Warrant  Shares  (which will be issued upon due and
proper  exercise of the  Warrant),  (y) the Option  Shares (which will be issued
upon due and  proper  exercise  of the  Options),  and (z) any shares of capital
stock issued or issuable as a dividend on or in exchange  for or otherwise  with
respect to any of the foregoing;  PROVIDED, HOWEVER, that Registrable Securities
shall not include any securities  that have been  previously  sold pursuant to a
registration  statement filed under the Act or under Rule 144 promulgated  under
the Securities Act, or which have otherwise been transferred in a transaction in
which the transferor's rights under this Agreement are not assigned,  or if such
securities are then eligible for sale under Rule 144, promulgated under the Act.

                        (iv)  "Registration   Statement"  means  a  registration
statement of the Company under the 1933 Act.

                  b.  Capitalized  terms used herein and not  otherwise  defined
herein shall have the respective  meanings set forth in the Alliance  Agreement,
the Advisory Agreement or the Stock Option Agreement.

            2. REGISTRATION.

                  a. DEMAND REGISTRATION.  Subject to Section 2(c) hereof, on or
after the initial  ninety (90) period  commencing on the date of this  Agreement
and upon the written demand of Investors holding at least  seventy-five  percent
(75%) of the Registrable  Securities (the  "REGISTRATION  DEMAND"),  the Company
shall prepare and file with the SEC a Registration Statement on Form S-3 (or, if
Form S-3 is not then  available,  on such form of  Registration  Statement as is
then available to effect a registration of the Registrable  Securities) covering
the resale of the Registrable  Securities,  which Registration Statement, to the
extent  allowable under the 1933 Act and the rules and  regulations  promulgated
thereunder  (including Rule 416), shall state that such  Registration  Statement
also covers such  indeterminate  number of additional  shares of Common Stock as
may become  issuable upon exercise of the Warrant  and/or the Options to prevent
dilution resulting from stock splits,  stock dividends or similar  transactions.
The  registration  rights of the  Investors  under this Section 2(a) may only be
exercised  on one  occasion  by the  Investors  and upon the SEC  declaring  the
Registration  Statement  covering such securities  effective,  the rights of the
Investors under this Section 2(a) shall terminate;  PROVIDED,  HOWEVER, that the
rights of the  Investors  under this  Section  2(a),  if  exercised  but delayed
pursuant to Section 2(c), shall not terminate (but shall only be delayed) by the
delay of exercise of such rights pursuant to Section 2(c).

                  b. PIGGY-BACK  REGISTRATIONS.  Subject to Section 2(c) hereof,
if at  any  time  prior  to  the  expiration  of  the  Registration  Period  (as
hereinafter  defined)  the  Company  shall  determine  to  file  with  the SEC a
Registration  Statement  relating  to an  offering  for its own  account  or the
account of others under the 1933 Act of any of its equity securities (other than
on Form S-4 or Form S-8 or their then equivalents  relating to equity securities
to be issued solely in connection with any acquisition of any entity or business
or equity securities issuable in



connection with stock option or other BONA FIDE,  employee  benefit plans),  the
Company shall send to each Investor who is entitled to registration rights under
this Section 2(b) written  notice of such  determination  and, if within fifteen
(15) days  after the  effective  date of such  notice,  such  Investor  shall so
request in writing, the Company shall include in such Registration Statement all
or  any  part  of  the  Registrable  Securities  such  Investor  requests  to be
registered,  except that if, in connection with any underwritten public offering
for the account of the Company the managing  underwriter(s) thereof shall impose
a  limitation  on the number of shares of Common  Stock which may be included in
the Registration Statement because, in such underwriter(s)' judgment,  marketing
or other  factors  dictate such  limitation  is necessary to  facilitate  public
distribution,   then  the  Company   shall  be  obligated  to  include  in  such
Registration  Statement only such limited portion of the Registrable  Securities
with respect to which such  Investor has  requested  inclusion  hereunder as the
underwriter shall permit. Any exclusion of Registrable  Securities shall be made
pro rata  among the  Investors  seeking  to include  Registrable  Securities  in
proportion to the number of Registrable Securities sought to be included by such
Investors; PROVIDED, HOWEVER, that the Company shall not exclude any Registrable
Securities unless the Company has first excluded all outstanding securities, the
holders  of which are not  entitled  to  inclusion  of such  securities  in such
Registration  Statement  or are not  entitled  to pro  rata  inclusion  with the
Registrable  Securities;  and PROVIDED,  FURTHER,  HOWEVER,  that,  after giving
effect to the  immediately  preceding  proviso,  any  exclusion  of  Registrable
Securities  shall be made pro rata with holders of other  securities  having the
right to  include  such  securities  in the  Registration  Statement  other than
holders  of  securities  entitled  to  inclusion  of  their  securities  in such
Registration  Statement  by reason of demand  registration  rights.  No right to
registration  of  Registrable  Securities  under  this  Section  2(b)  shall  be
construed to limit any registration  required under Section 2(a) hereof,  except
as  specifically  set forth in Section 2(a) above.  If an offering in connection
with which an Investor is entitled to registration under this Section 2(b) is an
underwritten  offering,  then each Investor  whose  Registrable  Securities  are
included in such  Registration  Statement shall,  unless otherwise agreed by the
Company,  offer and sell such Registrable Securities in an underwritten offering
using the same  underwriter or  underwriters  and,  subject to the provisions of
this Agreement, on the same terms and conditions as other shares of Common Stock
included in such underwritten offering.

                  c. RESTRICTION ON REGISTRATION.  In the event that the Company
has agreed, as a condition to any sale by the Company of securities the proceeds
of which  shall,  in whole or in part,  be used to fund the  obligations  of the
Company under the Alliance Agreement (each, a "SUBSEQUENT OFFERING"),  to file a
Registration  Statement with the SEC covering the securities sold, or underlying
the securities  sold, in such Subsequent  Offering and the investors  purchasing
securities  in  such  Subsequent  Offering  require,  as  a  condition  to  such
investment,  that the  Investors'  registration  rights under this  Agreement be
delayed,  the rights of the  Investors  under the Section  2(a) and Section 2(b)
shall be delayed,  at the option of the Company,  on one or more occasions for a
total  period  not to  exceed  ninety  (90)  days,  in the  aggregate,  from the
effective date of the Registration  Statement  covering the securities issued in
the Subsequent Offering.

            3. OBLIGATIONS OF THE COMPANY.

      In connection with the  registration of the  Registrable  Securities,  the
Company shall have the following obligations:



                  a. The Company shall prepare  promptly,  and file with the SEC
not later than forty-five (45) days of the receipt of the Registration Demand, a
Registration  Statement  with  respect to the number of  Registrable  Securities
provided in Section  2(a),  and  thereafter  use its best  efforts to cause such
Registration Statement relating to Registrable Securities to become effective as
soon as possible after such filing and keep the Registration Statement effective
pursuant  to Rule 415 at all times  until such date as is the earlier of (i) the
date on which all of the Registrable Securities have been sold and (ii) the date
on which the  Registrable  Securities  (in the opinion of counsel to the Initial
Investors)  may be  immediately  sold  to the  public  without  registration  or
restriction under the 1933 Act (the "REGISTRATION  PERIOD"),  which Registration
Statement  (including  any amendments or  supplements  thereto and  prospectuses
contained  therein) shall not contain any untrue statement of a material fact or
omit to state a material  fact  required to be stated  therein,  or necessary to
make the statements therein not misleading.

                  b.  The  Company  shall  prepare  and  file  with the SEC such
amendments  (including   post-effective   amendments)  and  supplements  to  the
Registration   Statements  and  the  prospectus  used  in  connection  with  the
Registration  Statements as may be necessary to keep the Registration Statements
effective at all times during the Registration  Period, and, during such period,
comply with the  provisions of the 1933 Act with respect to the  disposition  of
all Registrable Securities of the Company covered by the Registration Statements
until such time as all of such  Registrable  Securities have been disposed of in
accordance  with the intended  methods of  disposition  by the seller or sellers
thereof as set forth in the Registration Statements.

                  c.  The  Company  shall   furnish  to  each   Investor   whose
Registrable  Securities are included in a  Registration  Statement and its legal
counsel (i) promptly after the same is prepared and publicly distributed,  filed
with  the  SEC,  or  received  by the  Company,  one  copy of each  Registration
Statement and any amendment thereto, each preliminary  prospectus and prospectus
and  each  amendment  or  supplement  thereto,   and  (ii)  promptly  after  the
Registration  Statement is declared  effective by the SEC, such number of copies
of a prospectus,  including a preliminary  prospectus,  and all  amendments  and
supplements  thereto and such other  documents as such  Investor may  reasonably
request in order to facilitate  the  disposition of the  Registrable  Securities
owned by such Investor. The Company will immediately notify each Investor of the
effectiveness of each Registration  Statement or any  post-effective  amendment.
The Company will promptly respond to any and all comments received from the SEC,
with a view towards causing each Registration Statement or any amendment thereto
to be declared effective by the SEC as soon as practicable,  shall promptly file
an  acceleration  request as soon as  practicable  following  the  resolution or
clearance of all SEC comments or, if applicable,  following  notification by the
SEC that any such  Registration  Statement or any amendment  thereto will not be
subject to review and shall  promptly  file with the SEC a final  prospectus  as
soon as  practicable  following  receipt by the Company from the SEC of an order
declaring the Registration Statement effective.

                  d. The Company  shall use  reasonable  efforts to (i) register
and qualify the Registrable  Securities  covered by the Registration  Statements
under such other  securities  or "BLUE  SKY" laws of such  jurisdictions  in the
United  States  as  the  Investors  who  hold  a  majority  in  interest  of the
Registrable  Securities being offered reasonably request,  (ii) prepare and file
in those jurisdictions such amendments (including post-effective amendments) and
supplements  to such  registrations  and  qualifications  as may be necessary to
maintain the effectiveness thereof



during  the  Registration  Period,  (iii)  take  such  other  actions  as may be
necessary to maintain such  registrations  and  qualifications  in effect at all
times during the Registration Period, and (iv) take all other actions reasonably
necessary or advisable to qualify the  Registrable  Securities  for sale in such
jurisdictions;  PROVIDED,  HOWEVER,  that the  Company  shall not be required in
connection  therewith or as a condition thereto to (a) qualify to do business in
any  jurisdiction  where it would not  otherwise  be required to qualify but for
this  Section  3(d),  (b)  subject  itself  to  general  taxation  in  any  such
jurisdiction,  (c) file a general  consent  to  service  of  process in any such
jurisdiction,  (d) provide any undertakings that cause the Company undue expense
or burden,  or (e) make any change in its charter or bylaws,  which in each case
the Board of  Directors  of the  Company  determines  to be contrary to the best
interests of the Company and its shareholders.

                  e. As promptly as  practicable  after  becoming  aware of such
event,  the Company shall notify each Investor of the happening of any event, of
which the Company has knowledge, as a result of which the prospectus included in
any Registration Statement, as then in effect, includes an untrue statement of a
material fact or omission to state a material fact required to be stated therein
or necessary to make the  statements  therein not  misleading,  and use its best
efforts  promptly  to prepare a  supplement  or  amendment  to any  Registration
Statement to correct such untrue statement or omission,  and deliver such number
of copies of such  supplement or amendment to each Investor as such Investor may
reasonably  request;  PROVIDED  that,  the Company may delay the  disclosure  of
material non-public information concerning the Company (as well as prospectus or
Registration  Statement updating) the disclosure of which at the time is not, in
the good faith opinion of the Company,  in the best interests of the Company (an
"ALLOWED DELAY"); PROVIDED,  FURTHER, that the Company shall promptly (i) notify
the  Investors in writing of the  existence of material  non-public  information
giving  rise to an Allowed  Delay and (ii)  advise the  Investors  in writing to
cease all sales under such  Registration  Statement until the end of the Allowed
Delay. Upon expiration of the Allowed Delay, the Company shall again be bound by
the first sentence of this Section 3(e) with respect to the  information  giving
rise thereto.

                  f. The  Company  shall use its best  efforts  to  prevent  the
issuance  of  any  stop  order  or  other  suspension  of  effectiveness  of any
Registration  Statement,  and,  if  such an  order  is  issued,  to  obtain  the
withdrawal  of such order at the  earliest  possible  moment and to notify  each
Investor  who holds  Registrable  Securities  being sold (or, in the event of an
underwritten  offering, the managing underwriters) of the issuance of such order
and the resolution thereof.

                  g. The  Company  shall  cause all the  Registrable  Securities
covered by the Registration  Statement to be listed on each national  securities
exchange on which  securities  of the same class or series issued by the Company
are then listed,  if any, if the listing of such Registrable  Securities is then
permitted under the rules of such exchange.

                  h. At the request of the holders of a majority-in-interest  of
the Registrable Securities, the Company shall prepare and file with the SEC such
amendments   (including   post-effective   amendments)   and  supplements  to  a
Registration   Statement  and  any  prospectus   used  in  connection  with  the
Registration  Statement  as may be  necessary  in  order to  change  the plan of
distribution set forth in such Registration Statement.



            4. OBLIGATIONS OF THE INVESTORS.

      In connection with the  registration of the  Registrable  Securities,  the
Investors shall have the following obligations:

                  a. It shall be a condition precedent to the obligations of the
Company to complete the registration  pursuant to this Agreement with respect to
the  Registrable  Securities of a particular  Investor that such Investor  shall
furnish to the  Company  such  information  regarding  itself,  the  Registrable
Securities  held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the registration
of such  Registrable  Securities  and shall execute such documents in connection
with such registration as the Company may reasonably request.  The Company shall
notify each  Investor of the  information  the Company  requires  from each such
Investor.

                  b.  Each  Investor,  by  such  Investor's  acceptance  of  the
Registrable  Securities,  agrees to  cooperate  with the  Company as  reasonably
requested by the Company in connection  with the  preparation  and filing of the
Registration Statements hereunder, unless such Investor has notified the Company
in  writing  of such  Investor's  election  to  exclude  all of such  Investor's
Registrable Securities from the Registration Statements.

                  c. In the event Investors  holding a  majority-in-interest  of
the Registrable  Securities being registered determine to engage the services of
an  underwriter,  each Investor agrees to enter into and perform such Investor's
obligations  under an  underwriting  agreement,  in usual  and  customary  form,
including,  without  limitation,   customary  indemnification  and  contribution
obligations,  with the managing underwriter of such offering and take such other
actions as are  reasonably  required  in order to  expedite  or  facilitate  the
disposition of the Registrable Securities, unless such Investor has notified the
Company in writing of such Investor's election to exclude all of such Investor's
Registrable Securities from such Registration Statement.

                  d. Each Investor  agrees that, upon receipt of any notice from
the Company of the happening of any event of the kind  described in Section 3(e)
or 3(f), such Investor will immediately  discontinue  disposition of Registrable
Securities  pursuant to the  Registration  Statement  covering such  Registrable
Securities  until such Investor's  receipt of the copies of the  supplemented or
amended  prospectus  contemplated by Section 3(e) or 3(f) and, if so directed by
the Company,  such Investor  shall deliver to the Company (at the expense of the
Company) or destroy (and deliver to the Company a  certificate  of  destruction)
all  copies in such  Investor's  possession,  of the  prospectus  covering  such
Registrable Securities current at the time of receipt of such notice.

                  e.  No   Investor   may   participate   in  any   underwritten
registration  hereunder  unless such Investor (i) agrees to sell such Investor's
Registrable Securities on the basis provided in any underwriting arrangements in
usual and customary form entered into by the Company, (ii)completes and executes
all questionnaires, powers of attorney, indemnities, underwriting agreements and
other  documents  reasonably  required  under  the  terms  of such  underwriting
arrangements,  and (iii)  agrees to pay its pro rata  share of all  underwriting
discounts and



commissions and any expenses in excess of those payable by the Company  pursuant
to Section 5 below.

            5. EXPENSES OF REGISTRATION.

      All   reasonable   expenses,   other  than   underwriting   discounts  and
commissions,   incurred   in   connection   with   registrations,   filings   or
qualifications pursuant to Sections 2 and 3, including,  without limitation, all
registration,  listing and qualification fees, printers and accounting fees, and
the fees and  disbursements  of counsel  for the  Company  shall be borne by the
Company.

            6. INDEMNIFICATION.

      In the event any  Registrable  Securities  are included in a  Registration
Statement under this Agreement:

                  a. To the extent permitted by law, the Company will indemnify,
hold  harmless  and  defend  (i)  each  Investor  who  holds  such   Registrable
Securities, (ii) the directors,  officers, partners,  employees, agents and each
person who  controls  any  Investor  within  the  meaning of the 1933 Act or the
Securities  Exchange Act of 1934, as amended (the "1934 ACT"), if any, (iii) any
underwriter  (as  defined  in the  1933  Act)  for the  Investors,  and (iv) the
directors,  officers,  partners, employees and each person who controls any such
underwriter within the meaning of the 1933 Act or the 1934 Act, if any (each, an
"INDEMNIFIED  PERSON"),  against any joint or several losses,  claims,  damages,
liabilities  or expenses  (collectively,  together with actions,  proceedings or
inquiries by any regulatory or self-regulatory  organization,  whether commenced
or  threatened,  in respect  thereof,  "CLAIMS") to which any of them may become
subject  insofar as such Claims  arise out of or are based upon:  (i) any untrue
statement  or alleged  untrue  statement  of a material  fact in a  Registration
Statement or the omission or alleged  omission to state  therein a material fact
required  to  be  stated  or  necessary  to  make  the  statements  therein  not
misleading;  (ii) any untrue statement or alleged untrue statement of a material
fact contained in any preliminary prospectus if used prior to the effective date
of such Registration Statement, or contained in the final prospectus (as amended
or  supplemented,  if the  Company  files any  amendment  thereof or  supplement
thereto with the SEC) or the omission or alleged  omission to state  therein any
material fact  necessary to make the  statements  made therein,  in light of the
circumstances  under which the statements therein were made, not misleading;  or
(iii) any  violation  or alleged  violation  by the Company of the 1933 Act, the
1934 Act, any other law,  including,  without  limitation,  any state securities
law, or any rule or regulation  thereunder  relating to the offer or sale of the
Registrable  Securities (the matters in the foregoing  clauses (i) through (iii)
being,  collectively,  "VIOLATIONS").  Notwithstanding  anything to the contrary
contained herein, the indemnification  agreement contained in this Section 6(a):
(i) shall not apply to a Claim  arising out of or based upon a  Violation  which
occurs in reliance upon and in conformity with information  furnished in writing
to the Company by any  Indemnified  Person or underwriter  for such  Indemnified
Person expressly for use in connection with the preparation of such Registration
Statement  or  any  such  amendment  thereof  or  supplement  thereto,  if  such
prospectus  was timely made  available  by the Company  pursuant to Section 3(c)
hereof;  (ii) shall not apply to amounts paid in settlement of any Claim if such
settlement is effected  without the prior written consent of the Company,  which
consent  shall not be  unreasonably  withheld;  and (iii)  with  respect  to any
preliminary prospectus, shall not inure to the benefit of any Indemnified



Person if the untrue  statement  or omission of material  fact  contained in the
preliminary  prospectus  was corrected on a timely basis in the  prospectus,  as
then  amended  or  supplemented,  such  corrected  prospectus  was  timely  made
available by the Company  pursuant to Section 3(c) hereof,  and the  Indemnified
Person was promptly advised in writing not to use the incorrect prospectus prior
to  the  use  giving  rise  to  a  Violation   and  such   Indemnified   Person,
notwithstanding  such advice, used it. Such indemnity shall remain in full force
and  effect  regardless  of  any  investigation  made  by or on  behalf  of  the
Indemnified Person and shall survive the transfer of the Registrable  Securities
by the Investors pursuant to Section 7.

                  b. In connection with any  Registration  Statement in which an
Investor is  participating,  each such Investor agrees severally and not jointly
to  indemnify,  hold  harmless  and  defend,  to the same extent and in the same
manner set forth in Section 6(a), the Company,  each of its  directors,  each of
its  officers who signs the  Registration  Statement,  each person,  if any, who
controls  the Company  within the  meaning of the 1933 Act or the 1934 Act,  any
underwriter  and  any  other  shareholder  selling  securities  pursuant  to the
Registration  Statement  or any of its  directors  or officers or any person who
controls such  shareholder or underwriter  within the meaning of the 1933 Act or
the  1934  Act  (collectively  and  together  with  an  Indemnified  Person,  an
"INDEMNIFIED PARTY"), against any Claim to which any of them may become subject,
under the 1933 Act, the 1934 Act or otherwise,  insofar as such Claim arises out
of or is based upon any Violation by such  Investor,  in each case to the extent
(and only to the extent)  that such  Violation  occurs in  reliance  upon and in
conformity  with written  information  furnished to the Company by such Investor
expressly for use in connection with such Registration Statement; and subject to
Section 6(c) such Investor will reimburse any legal or other expenses  (promptly
as such  expenses are incurred and are due and payable)  reasonably  incurred by
them in connection  with  investigating  or defending any such Claim;  PROVIDED,
HOWEVER,  that the indemnity  agreement contained in this Section 6(b) shall not
apply to amounts paid in settlement of any Claim if such  settlement is effected
without the prior written  consent of such Investor,  which consent shall not be
unreasonably withheld;  PROVIDED,  FURTHER,  HOWEVER, that the Investor shall be
liable under this Agreement (including this Section 6(b) and Section 7) for only
that amount as does not exceed the net proceeds to such  Investor as a result of
the sale of Registrable Securities pursuant to such Registration Statement. Such
indemnity shall remain in full force and effect  regardless of any investigation
made by or on behalf of such Indemnified Party and shall survive the transfer of
the   Registrable   Securities   by  the   Investors   pursuant  to  Section  7.
Notwithstanding  anything to the contrary contained herein, the  indemnification
agreement  contained  in this  Section  6(b)  with  respect  to any  preliminary
prospectus shall not inure to the benefit of any Indemnified Party if the untrue
statement or omission of material fact contained in the  preliminary  prospectus
was  corrected  on a  timely  basis  in  the  prospectus,  as  then  amended  or
supplemented.

                  c.  Promptly  after  receipt  by  an  Indemnified   Person  or
Indemnified  Party  under this  Section 6 of notice of the  commencement  of any
action  (including  any  governmental   action),   such  Indemnified  Person  or
Indemnified Party shall, if a Claim in respect thereof is to be made against any
indemnifying  party under this  Section 6, deliver to the  indemnifying  party a
written notice of the commencement  thereof,  and the  indemnifying  party shall
have the right to participate in, and, to the extent the  indemnifying  party so
desires,  jointly with any other indemnifying party similarly noticed, to assume
control  of the  defense  thereof  with  counsel  mutually  satisfactory  to the
indemnifying  party and the Indemnified  Person or the Indemnified Party, as the
case may be. The failure to deliver  written  notice to the  indemnifying  party
within a



reasonable  time of the  commencement  of any such action shall not relieve such
indemnifying  party of any liability to the  Indemnified  Person or  Indemnified
Party under this Section 6, except to the extent that the indemnifying  party is
actually prejudiced in its ability to defend such action.

            7. ASSIGNMENT OF REGISTRATION RIGHTS.

      The rights under this Agreement shall be  automatically  assignable by the
Investors to any transferee of all or any portion of Registrable  Securities if:
(i) the  Investor  agrees in writing with the  transferee  or assignee to assign
such rights,  and a copy of such  agreement is furnished to the Company within a
reasonable time after such assignment,  (ii) the Company is, within a reasonable
time after such transfer or assignment, furnished with written notice of (a) the
name and address of such  transferee or assignee,  and (b) the  securities  with
respect to which such  registration  rights are being  transferred  or assigned,
(iii)  following  such transfer or assignment,  the further  disposition of such
securities by the  transferee  or assignee is restricted  under the 1933 Act and
applicable  state  securities  laws,  (iv) at or  before  the time  the  Company
receives the written notice  contemplated  by clause (ii) of this sentence,  the
transferee or assignee  agrees in writing with the Company to be bound by all of
the  provisions  contained  herein,  (v) such  transfer  shall have been made in
accordance with the applicable  requirements  of the Alliance  Agreement and the
Stock  Option  Agreement,  and (vi)  such  transferee  shall  be an  "ACCREDITED
INVESTOR" as that term defined in Rule 501 of Regulation D promulgated under the
1933 Act.

            8. AMENDMENT OF REGISTRATION RIGHTS.

      Provisions of this Agreement may be amended and the observance thereof may
be waived (either generally or in a particular instance and either retroactively
or  prospectively),  only with written  consent of the Company and Investors who
hold a majority interest of the Registrable Securities.  Any amendment or waiver
effected in  accordance  with this Section 8 shall be binding upon each Investor
and the Company.

            9. MISCELLANEOUS.

                  a. A person or entity is deemed to be a holder of  Registrable
Securities  whenever  such  person or entity  owns of  record  such  Registrable
Securities.  If  the  Company  receives  conflicting  instructions,  notices  or
elections  from  two or more  persons  or  entities  with  respect  to the  same
Registrable  Securities,  the Company shall act upon the basis of  instructions,
notice  or  election  received  from the  registered  owner of such  Registrable
Securities.

                  b. All notices  required or  permitted  hereunder  shall be in
writing and shall be deemed effectively given: (a) upon personal delivery to the
party to be notified, (b) when sent by confirmed facsimile if sent during normal
business hours of the recipient, if not, then on the next business day, (c) five
(5) days after having been sent by registered or certified mail,  return receipt
requested,  postage prepaid,  or (d) one (1) day after deposit with a nationally
recognized  overnight  courier,  specifying  next  day  delivery,  with  written
verification of receipt.  All communications  shall be sent to a party hereto at
the  address  set forth for such party on the  signature  page hereof or at such
other  address  as such party may  designate  by ten (10) days  advance  written
notice to the other party hereto.



                  c. It is agreed  that no delay or  omission  to  exercise  any
right,  power or remedy  accruing  to any  party,  upon any  breach,  default or
noncompliance by any other party,  shall impair any such right, power or remedy,
nor  shall  it be  construed  to be a  waiver  of any such  breach,  default  or
noncompliance,  or any  acquiescence  therein,  or of or in any similar  breach,
default or noncompliance thereafter occurring.

                  d. In case any provision of this Agreement, or portion hereof,
shall  be  invalid,  illegal  or  unenforceable,   the  validity,  legality  and
enforceability  of the remaining  provisions shall not in any way be affected or
impaired thereby.

                  e. This Agreement,  together with the other Strategic Alliance
Documents (as defined in the Alliance Agreement), constitute the full and entire
understanding  and  agreement  between  the  parties  with regard to the subject
matters  hereof and  thereof  and,  except as  otherwise  specifically  provided
therein,  no party  shall be liable  or bound to any other in any  manner by any
other representations,  warranties, covenants or agreements with respect to such
subject matters.

                  f. Except as otherwise  expressly  provided herein and subject
to the  requirements of Section 7 hereof,  the provisions  hereof shall inure to
the benefit of, be binding upon, and be  enforceable  by, the parties hereto and
their respective successors and assigns.

                  g.  The  titles  of  the  sections  and  subsections  of  this
Agreement are for  convenience of reference only and are not to be considered in
construing this Agreement.

                  h.  This   Agreement   may  be   executed  in  any  number  of
counterparts,  each of which  shall be an  original,  but all of which  together
shall constitute one agreement.

                  i. Each of the parties hereto shall, at any time and from time
to time after the date  hereof,  at the request and expense of the other  party,
(i)  promptly and duly  execute and  deliver,  or cause to be duly  executed and
delivered to the requested  person,  all such further documents and instruments,
and (ii) take or cause to be taken all such other and further  actions,  in each
case as may be  reasonably  requested by the other party to implement and effect
the terms of this Agreement.

                  j. Except as otherwise provided herein, all consents and other
determinations  to be made by the Investors  pursuant to this Agreement shall be
made by Investors holding a majority of the Registrable  Securities,  determined
as if all of the Warrants and Options then  outstanding have been converted into
for Registrable Securities.

                  k.  The  Company  acknowledges  that  a  breach  by it of  its
obligations  hereunder will cause irreparable harm to each Investor by vitiating
the intent and purpose of the transactions contemplated hereby. Accordingly, the
Company  acknowledges that the remedy at law for breach of its obligations under
this  Agreement  will be  inadequate  and  agrees,  in the  event of a breach or
threatened  breach by the Company of any of the provisions under this Agreement,
that each  Investor  shall be  entitled,  in  addition  to all  other  available
remedies  in law or in  equity,  and in  addition  to the  penalties  assessable
herein,  to an injunction or injunctions  restraining,  preventing or curing any
breach of this Agreement and to enforce specifically the terms and



provisions  hereof,  without the necessity of showing  economic loss and without
any bond or other security being required.

                  l. The language  used in this  Agreement  will be deemed to be
the language chosen by the parties to express their mutual intent,  and no rules
of strict construction will be applied against any party.

                  m.  THIS  AGREEMENT  SHALL BE  GOVERNED  BY AND  CONSTRUED  IN
ACCORDANCE  WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT GIVING EFFECT TO ANY
CHOICE OR  CONFLICT  OF LAWS  PROVISIONS).  EACH OF THE  PARTIES  HERETO  HEREBY
IRREVOCABLY AND  UNCONDITIONALLY  SUBMITS TO THE  JURISDICTION OF ANY FEDERAL OR
STATE COURT OF NEW YORK SITTING IN NEW YORK CITY AND IRREVOCABLY AGREES THAT ALL
ACTIONS OR  PROCEEDINGS  ARISING  OUT OF OR RELATING  TO THIS  AGREEMENT  OR THE
TRANSACTIONS  CONTEMPLATED HEREBY SHALL BE LITIGATED EXCLUSIVELY IN SUCH COURTS.
EACH OF THE PARTIES HERETO AGREES NOT TO COMMENCE ANY LEGAL  PROCEEDING  RELATED
HERETO EXCEPT IN SUCH COURT. EACH OF THE PARTIES HERETO  IRREVOCABLY  WAIVES ANY
OBJECTION  WHICH IT MAY NOW OR HEREAFTER  HAVE TO THE LAYING OF THE VENUE OF ANY
SUCH   PROCEEDING  IN  ANY  SUCH  COURT  AND  HEREBY  FURTHER   IRREVOCABLY  AND
UNCONDITIONALLY  WAIVES  AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT
ANY SUCH ACTION,  SUIT OR PROCEEDING  BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT
IN AN  INCONVENIENT  FORUM.  EACH OF THE PARTIES  HERETO HEREBY  WAIVES,  TO THE
FULLEST EXTENT  PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY LITIGATION  DIRECTLY OR INDIRECTLY  ARISING OUT OF, UNDER
OR IN CONNECTION WITH THIS  AGREEMENT.  EACH OF THE PARTIES HERETO (A) CERTIFIES
THAT NO  REPRESENTATIVE,  AGENT OR ATTORNEY OF THE OTHER PARTY HAS  REPRESENTED,
EXPRESSLY  OR  OTHERWISE,  THAT THE  OTHER  PARTY  WOULD  NOT,  IN THE  EVENT OF
LITIGATION,  SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT BOTH
PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS  AGREEMENT,  BY, AMONG OTHER
THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9(m).

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]



      IN WITNESS WHEREOF, the Company and the undersigned Initial Investors have
caused this Agreement to be duly executed as of the date first above written.


                                              ELITE PHARMACEUTICALS, INC.


                                              By: /s/ Bernard Berk
                                                  ------------------------------
                                                  Name:  Bernard Berk
                                                  Title: Chief Executive Officer

                                              ADDRESS:

                                              Elite Pharmaceuticals, Inc.
                                              165 Ludlow Avenue
                                              Northvale, New Jersey 07647
                                              Attention: Chief Executive Officer
                                              Facsimile: (201) 391-7693


                                              /s/ Veerappan S. Subramanian
                                              ----------------------------------
                                              Veerappan S. Subramanian

                                              ADDRESS:

                                              475 Bernardsville Road
                                              Mendham, New Jersey 07945
                                              Facsimile: (908) 766-4006


                                              VGS Pharma, LLC


                                              By: /s/ Anu R. Subramanian
                                                  ------------------------------
                                                  Anu R. Subramanian, Manager

                                              ADDRESS:

                                              475 Bernardsville Road
                                              Mendham, New Jersey 07945
                                              Facsimile: (908) 766-4006